Q3 2024 · 13F-HR
Parkman Healthcare Partners LLCholdings as filed
Filed 2024-11-14 · accession 0001420506-24-002511
$783.4M
Reported value
93
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $37.5M | 4.78% | 447,196 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $37.2M | 4.74% | 159,689 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $35.8M | 4.57% | 40,384 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $32.3M | 4.12% | 292,593 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $24.5M | 3.13% | 421,782 | Common | SOLE |
| 879369106 | TFX | TELEFLEX INCORPORATED | $23.8M | 3.04% | 96,144 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $22.9M | 2.93% | 64,031 | Common | SOLE |
| 56400P706 | MNKD | MANNKIND CORP | $20.8M | 2.65% | 3,304,085 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $18.9M | 2.41% | 755,244 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $18.0M | 2.30% | 626,452 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $17.7M | 2.26% | 241,575 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $17.5M | 2.24% | 657,070 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $16.4M | 2.09% | 491,272 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $15.7M | 2.00% | 1,025,754 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $15.6M | 1.99% | 93,753 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $15.2M | 1.94% | 1,086,067 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $15.0M | 1.91% | 129,840 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $14.9M | 1.90% | 130,249 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $14.5M | 1.85% | 60,011 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $14.1M | 1.80% | 123,601 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $12.9M | 1.64% | 924,140 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $12.7M | 1.62% | 285,099 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $10.8M | 1.38% | 129,025 | Common | SOLE |
| 80810D103 | SDGR | SCHRODINGER INC | $10.4M | 1.32% | 559,105 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $10.1M | 1.29% | 28,000 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $10.1M | 1.29% | 445,396 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $9.9M | 1.26% | 438,971 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $9.8M | 1.25% | 508,283 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $9.7M | 1.23% | 425,000 | Common | SOLE |
| N72482149 | — | QIAGEN NV | $9.6M | 1.23% | 210,769 | Common | SOLE |
| 78349D107 | RXST | RXSIGHT INC | $9.1M | 1.16% | 184,320 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $9.1M | 1.16% | 497,870 | Common | SOLE |
| 74834L100 | DGX | QUEST DIAGNOSTICS INC | $8.5M | 1.09% | 55,000 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $8.4M | 1.08% | 296,071 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $8.4M | 1.07% | 763,747 | Common | SOLE |
| 05368M106 | PPHMEUR | AVID BIOSERVICES INC | $8.2M | 1.05% | 719,965 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $8.1M | 1.03% | 72,256 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $7.7M | 0.98% | 907,294 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $7.5M | 0.96% | 191,658 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $7.5M | 0.96% | 26,212 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $7.2M | 0.92% | 195,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $7.0M | 0.89% | 25,485 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $6.5M | 0.83% | 605,318 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $6.1M | 0.78% | 109,468 | Common | SOLE |
| 126638105 | CVRX | CVRX INC | $6.0M | 0.77% | 682,897 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $5.9M | 0.76% | 1,716,132 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $5.8M | 0.74% | 412,888 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $5.6M | 0.71% | 66,492 | Common | SOLE |
| 71377E105 | PFMTUSD | PERFORMANT FINL CORP | $5.4M | 0.69% | 1,440,838 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $5.3M | 0.68% | 101,729 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $5.3M | 0.68% | 250,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $5.2M | 0.66% | 102,813 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $5.1M | 0.66% | 285,294 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $4.7M | 0.60% | 70,588 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $4.6M | 0.59% | 138,100 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $4.6M | 0.58% | 545,751 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $4.4M | 0.56% | 347,541 | Common | SOLE |
| 92337F107 | VCYT | VERACYTE INC | $4.4M | 0.56% | 129,260 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $4.0M | 0.51% | 77,623 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $3.5M | 0.45% | 464,048 | Common | SOLE |
| 219798105 | QDEL | QUIDELORTHO CORP | $3.4M | 0.44% | 75,000 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $3.3M | 0.43% | 254,827 | Common | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $3.3M | 0.42% | 139,357 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $3.2M | 0.41% | 237,820 | Common | SOLE |
| 53228F101 | LFST | LIFESTANCE HEALTH GROUP INC | $3.1M | 0.40% | 450,000 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $3.0M | 0.38% | 126,471 | Common | SOLE |
| 825704109 | SIBN | SI-BONE INC | $2.6M | 0.33% | 185,316 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $2.6M | 0.33% | 35,433 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $2.4M | 0.31% | 219,451 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $2.4M | 0.31% | 23,400 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $2.4M | 0.30% | 96,183 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $2.3M | 0.29% | 45,349 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HLDGS INC | $2.2M | 0.28% | 396,336 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $2.1M | 0.27% | 345,902 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $1.9M | 0.25% | 328,613 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $1.9M | 0.24% | 127,812 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $1.9M | 0.24% | 455,477 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $1.8M | 0.23% | 44,301 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $1.7M | 0.22% | 105,334 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $1.7M | 0.22% | 206,444 | Common | SOLE |
| 29772L108 | ETON | ETON PHARMACEUTICALS INC | $1.6M | 0.20% | 260,226 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $1.5M | 0.19% | 903,140 | Common | SOLE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $1.4M | 0.18% | 278,775 | Common | SOLE |
| 02080L102 | TKNO | ALPHA TEKNOVA INC | $1.2M | 0.16% | 251,026 | Common | SOLE |
| 00974H104 | — | AKOYA BIOSCIENCES INC | $1.0M | 0.13% | 376,131 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $874,617 | 0.11% | 126,940 | Common | SOLE |
| M40527109 | ENTX | ENTERA BIO LTD | $781,044 | 0.10% | 411,076 | Common | SOLE |
| 76152G100 | — | REVIVA PHARMACEUTCLS HLDGS I | $737,571 | 0.09% | 512,202 | Common | SOLE |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $547,974 | 0.07% | 818,727 | Common | SOLE |
| 268311107 | EDAP | EDAP TMS S A | $394,822 | 0.05% | 154,832 | Common | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $381,589 | 0.05% | 202,973 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $291,820 | 0.04% | 102,393 | Common | SOLE |
| 45779A846 | NSPR | INSPIREMD INC | $278,937 | 0.04% | 104,081 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.